Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 11 | 1 | 2 | 0 | 8 |
| Cost of Goods | 4 | 0 | 1 | 14 | 3 |
| Gross Profit | 7 | 0 | 2 | -9 | 5 |
| Operating Expenses | 508 | 1,799 | 488 | 379 | 700 |
| Operating Income | -497 | -1,799 | -486 | -374 | -692 |
| Interest Expense | 339 | 338 | 336 | 227 | 247 |
| Other Income | 232 | -390 | -1,591 | 2,998 | -585 |
| Pre-tax Income | -603 | -2,526 | -2,413 | 2,396 | -1,524 |
| Net Income Continuous | -603 | -2,526 | -2,413 | 2,396 | -1,524 |
| Net Income | $-603 | $-2,526 | $-2,413 | $2,396 | $-1,524 |
| EPS Basic Total Ops | 0.00 | -0.02 | -0.03 | 0.05 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | -0.02 | -0.03 | 0.06 | -0.02 |
| EPS Diluted Total Ops | 0.00 | -0.02 | -0.03 | 0.05 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | -0.02 | -0.03 | 0.06 | -0.02 |
| EBITDA(a) | $-304 | $-1,609 | $-293 | $-177 | $-500 |